Literature DB >> 22407669

Should procalcitonin be used as a routine biomarker of bacterial infection?

R R Das.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22407669     DOI： 10.1007/s15010-012-0253-6

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  10 in total

1.  Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.

Authors:  Mirjam Christ-Crain; Daiana Jaccard-Stolz; Roland Bingisser; Mikael M Gencay; Peter R Huber; Michael Tamm; Beat Müller
Journal:  Lancet       Date:  2004-02-21       Impact factor: 79.321

Review 2.  Management of community-acquired pneumonia in adults.

Authors:  Grant W Waterer; Jordi Rello; Richard G Wunderink
Journal:  Am J Respir Crit Care Med       Date:  2010-08-06       Impact factor: 21.405

Review 3.  Use of plasma procalcitonin levels as an adjunct to clinical microbiology.

Authors:  David N Gilbert
Journal:  J Clin Microbiol       Date:  2010-04-26       Impact factor: 5.948

4.  Accuracy of the cerebrospinal fluid results to differentiate bacterial from non bacterial meningitis, in case of negative gram-stained smear.

Authors:  Patrick Ray; Ghislaine Badarou-Acossi; Alain Viallon; David Boutoille; Martine Arthaud; David Trystram; Bruno Riou
Journal:  Am J Emerg Med       Date:  2007-02       Impact factor: 2.469

5.  Evaluation of potential biomarkers for the discrimination of bacterial and viral infections.

Authors:  P Chalupa; O Beran; H Herwald; N Kaspříková; M Holub
Journal:  Infection       Date:  2011-07-01       Impact factor: 3.553

6.  The utility of procalcitonin in diagnosis of H1N1 influenza in intensive care patients.

Authors:  N E Hammond; A Corley; J F Fraser
Journal:  Anaesth Intensive Care       Date:  2011-03       Impact factor: 1.669

7.  Serum procalcitonin levels in bacterial and abacterial meningitis.

Authors:  S Schwarz; M Bertram; S Schwab; K Andrassy; W Hacke
Journal:  Crit Care Med       Date:  2000-06       Impact factor: 7.598

8.  Clinical characterisation of pneumonia caused by atypical pathogens combining classic and novel predictors.

Authors:  M Masiá; F Gutiérrez; S Padilla; B Soldán; C Mirete; C Shum; I Hernández; G Royo; A Martin-Hidalgo
Journal:  Clin Microbiol Infect       Date:  2007-02       Impact factor: 8.067

9.  In critically ill patients the procalcitonin level can be misleading.

Authors:  Jacqueline Koeze; M G Ron Hendrix; Frank A J T M van den Bergh; René M L Brouwer; Jan G Zijlstra
Journal:  Crit Care       Date:  2011-04-28       Impact factor: 9.097

10.  Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study.

Authors:  E Cuquemelle; F Soulis; D Villers; F Roche-Campo; C Ara Somohano; M Fartoukh; A Kouatchet; B Mourvillier; J Dellamonica; W Picard; M Schmidt; T Boulain; C Brun-Buisson
Journal:  Intensive Care Med       Date:  2011-03-03       Impact factor: 17.440
  10 in total
  2 in total

1.  Measuring synovial fluid procalcitonin levels in distinguishing cases of septic arthritis, including prosthetic joints, from other causes of arthritis and aseptic loosening.

Authors:  K Saeed; M Dryden; A Sitjar; G White
Journal:  Infection       Date:  2013-05-04       Impact factor: 3.553

2.  Procalcitonin levels in fresh serum and fresh synovial fluid for the differential diagnosis of knee septic arthritis from rheumatoid arthritis, osteoarthritis and gouty arthritis.

Authors:  Chenggong Wang; DA Zhong; Qiande Liao; Lingyu Kong; Ansong Liu; Han Xiao
Journal:  Exp Ther Med       Date:  2014-07-29       Impact factor: 2.447
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.